Launch week offerEnds in00h00m00s

Carl Ernst

Has grant

Associate professor

McGill University
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Resolving roadblocks to clinical trial readiness for rare brain disease gene therapy

Open Date: 2024-04-01

Close Date: 2028-03-31

Grant: Open

Mechanisms of FOXG1 deficiency in brain cell proliferation and patterning

Open Date: 2023-04-01

Close Date: 2028-03-31

Grant: Close

Uncovering the molecular mechanism underlying KDM6A in Kabuki Syndrome

Open Date: 2023-01-01

Close Date: 2025-12-31

Grant: Close

Modélisation des maladies neurodéveloppementales dans des cellules d'origine humaine

Open Date: 2022-04-01

Close Date: 2025-03-31

Grant: Close

Development and preclinical testing in human cell models and transgenic mice of a novel treatment for Schinzel-Giedion Syndrome

Open Date: 2021-01-01

Close Date:

Articles (3)

Year:

2025

Year:

2025

FOXG1 is a critical transcription factor in human brain where loss-of-function mutations cause a severe neurodevelopmental disorder, while increased FOXG1 expression is frequently observed in glioblastoma. FOXG1 is an inhibitor of cell patterning and an activator of cell proliferation in chordate model organisms but different mechanisms have been proposed as to how this occurs. To identify genomic targets of FOXG1 in human neural progenitor cells (NPCs), we engineered a cleavable reporter construct in endogenous FOXG1 and performed chromatin immunoprecipitation (ChIP) sequencing. We also performed deep RNA sequencing of NPCs from two females with loss-of-function mutations in FOXG1 and their healthy biological mothers. Integrative analyses of RNA and ChIP sequencing data showed that cell cycle regulation and Bone Morphogenic Protein (BMP) repression gene ontology categories were over-represented as FOXG1 targets. Using engineered brain cell lines, we show that FOXG1 specifically activates SMAD7 and represses CDKN1B. Activation of SMAD7 which inhibits BMP signaling may be one way that FOXG1 patterns the forebrain, while repression of cell cycle regulators such as CDKN1B may be one way that FOXG1 expands the NPC pool to ensure proper brain size. Our data reveal novel mechanisms on how FOXG1 may control forebrain patterning and cell proliferation in human brain development.

Year:

2023

Collaborators (1)

Shaima Alsuwaidi

Lecturer

mohammed bin rashid university of medicine and health sciences

UNITED ARAB EMIRATES
View details